These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 19415061)

  • 21. In vivo evaluation of a simvastatin-loaded nanostructured lipid carrier for bone tissue regeneration.
    Yue X; Niu M; Zhang T; Wang C; Wang Z; Wu W; Zhang Q; Lai C; Zhou L
    Nanotechnology; 2016 Mar; 27(11):115708. PubMed ID: 26881419
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Calcium channel blocker-simvastatin interaction.
    Tobert JA; Vega JM; Dobrinska M; Gruer PJ
    Clin Pharmacol Ther; 1999 May; 65(5):583-5. PubMed ID: 10340925
    [No Abstract]   [Full Text] [Related]  

  • 23. Letter by Namazi regarding article "Simvastatin attenuates cisplatin-induced kidney and liver damage in rats".
    Namazi H
    Toxicology; 2008 May; 247(2-3):161. PubMed ID: 18406033
    [No Abstract]   [Full Text] [Related]  

  • 24. Hypercholesterolaemia induces early renal lesions characterized by upregulation of MMP-9 and iNOS and ET(A)R: alleviated by a dual endothelin receptor antagonist CPU0213 and simvastatin.
    Luo L; Zheng YF; Dai Y; Dai DZ
    J Pharm Pharmacol; 2009 Jun; 61(6):775-80. PubMed ID: 19505368
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreasing the expression of LFA-1 and ICAM-1 as well as hindering their interaction as the major mechanism for statin-induced neutrophil dysfunction.
    Namazi MR
    Ann Thorac Surg; 2007 Dec; 84(6):2137-8. PubMed ID: 18036969
    [No Abstract]   [Full Text] [Related]  

  • 26. [Quanlitatitive analysis the effect of simvastain on cancellous bone formation around implant by micro-CT].
    Zhao B; Wu F; Lü J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2011 Dec; 46(12):765. PubMed ID: 22333362
    [No Abstract]   [Full Text] [Related]  

  • 27. Drug use review matters.
    Mueting M
    Nebr Nurse; 2007; 40(3):28. PubMed ID: 17915614
    [No Abstract]   [Full Text] [Related]  

  • 28. The effect of graft application and simvastatin treatment on tibial bone defect in rats. A histological and immunohistochemical study.
    Laçin N; İzol BS; Özkorkmaz EG; Deveci B; Tuncer MC
    Acta Cir Bras; 2019 May; 34(4):e201900408. PubMed ID: 31066788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of platelet-rich arterial thrombus in vivo: acute antithrombotic effect of intravenous HMG-CoA reductase therapy.
    Obi C; Wysokinski W; Karnicki K; Owen WG; McBane RD
    Arterioscler Thromb Vasc Biol; 2009 Sep; 29(9):1271-6. PubMed ID: 19667107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Statin drugs and the risk of fracture.
    El-Sohemy A
    JAMA; 2000 Oct; 284(15):1921-2. PubMed ID: 11035877
    [No Abstract]   [Full Text] [Related]  

  • 31. Application of a 3,3-diphenylpentane skeleton as a multi-template for creation of HMG-CoA reductase inhibitors.
    Hosoda S; Matsuda D; Tomoda H; Hashimoto M; Aoyama H; Hashimoto Y
    Bioorg Med Chem Lett; 2009 Aug; 19(15):4228-31. PubMed ID: 19502059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined therapy with simvastatin and bone marrow-derived mesenchymal stem cells increases benefits in infarcted swine hearts.
    Yang YJ; Qian HY; Huang J; Li JJ; Gao RL; Dou KF; Yang GS; Willerson JT; Geng YJ
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2076-82. PubMed ID: 19762786
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identified biosynthetic pathway of aspergiolide A and a novel strategy to increase its production in a marine-derived fungus Aspergillus glaucus by feeding of biosynthetic precursors and inhibitors simultaneously.
    Sun X; Zhou X; Cai M; Tao K; Zhang Y
    Bioresour Technol; 2009 Sep; 100(18):4244-51. PubMed ID: 19386490
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mesenchymal stromal cell therapy and treatment of ischaemic disease.
    Rasmussen JG; Simonsen U
    Basic Clin Pharmacol Toxicol; 2012 Jun; 110(6):483-6. PubMed ID: 22510155
    [No Abstract]   [Full Text] [Related]  

  • 35. Influence of statin treatment on platelet inhibition by clopidogrel - a randomized comparison of rosuvastatin, atorvastatin and simvastatin co-treatment.
    Malmström RE; Ostergren J; Jørgensen L; Hjemdahl P;
    J Intern Med; 2009 Nov; 266(5):457-66. PubMed ID: 19549094
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of usefulness of simvastatin 20 mg versus 80 mg in preventing contrast-induced nephropathy in patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Xinwei J; Xianghua F; Jing Z; Xinshun G; Ling X; Weize F; Guozhen H; Yunfa J; Weili W; Shiqiang L
    Am J Cardiol; 2009 Aug; 104(4):519-24. PubMed ID: 19660605
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of sitagliptin on the pharmacokinetics of simvastatin.
    Bergman AJ; Cote J; Maes A; Zhao JJ; Roadcap BA; Sun L; Valesky RJ; Yang A; Keymeulen B; Mathijs Z; De Smet M; Laethem T; Davies MJ; Wagner JA; Herman GA
    J Clin Pharmacol; 2009 Apr; 49(4):483-8. PubMed ID: 19204138
    [No Abstract]   [Full Text] [Related]  

  • 38. Challenges of cognitive research in neurofibromatosis type 1.
    Acosta MT
    Lancet Neurol; 2013 Nov; 12(11):1040-1. PubMed ID: 24107290
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparative effect of atorvastatin (80 mg) versus simvastatin (20 to 40 mg) in preventing hospitalizations for heart failure in patients with previous myocardial infarction.
    Strandberg TE; Holme I; Faergeman O; Kastelein JJ; Lindahl C; Larsen ML; Olsson AG; Pedersen TR; Tikkanen MJ;
    Am J Cardiol; 2009 May; 103(10):1381-5. PubMed ID: 19427432
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A patient with hyper-IgD syndrome responding to simvastatin treatment.
    Attout H; Guez S; Ranaivo I; Jameerbaccus N; Series C
    Eur J Intern Med; 2008 Dec; 19(8):e82-3. PubMed ID: 19046710
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.